Stock ENTELLUS MEDICAL INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Entellus Medical Inc

Equities

US29363K1051

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers
GL
Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction
GL
Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATERA
GL
Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash
GL
Entellus Medical to Participate in Upcoming Investor Conferences
GL
Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation
GL
Entellus Medical Announces Third Quarter 2017 Financial Results
GL
Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®
GL
Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017
GL
Entellus Medical Announces New Employee Inducement Option Grants
GL
Entellus Medical Announces Second Quarter 2017 Financial Results
GL
Entellus Medical to Present at the Canaccord Genuity Annual Growth Conference
GL
Entellus Medical to Report Second Quarter 2017 Financial Results August 3, 2017
GL
Entellus Medical Announces Definitive Agreement to Acquire Spirox
GL
Entellus Medical to Present at the William Blair Growth Stock Conference
GL
The Centers for Medicare & Medicaid Services (CMS) Establishes Coding and Payment for Eustachian Tube Balloon Dilation
GL
Entellus Medical Announces First Quarter 2017 Financial Results
GL
Entellus Medical to Present at the Deutsche Bank Annual Health Care Conference
GL
Entellus Medical to Report First Quarter 2017 Financial Results on May 3, 2017
GL
Entellus Medical Receives FDA 510(k) Clearance for Eustachian Tube Indication
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Entellus Medical Inc